Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

genesis pharmaceuticals ltd - betahistine dihydrochloride - oral tablet - 8mg

Malta - angličtina - Medicines Authority

azure pharmaceuticals ltd 12 hamilton drive, the rock road, blackrock, co. louth a91 t997, ireland - tablet - betahistine dihydrochloride 8 mg - other nervous system drugs

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - betahistine dihydrochloride - oral tablet - 8mg

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

accord healthcare limited - betahistine dihydrochloride - tablets - 8 milligram - betahistine

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - betahistine dihydrochloride - tablet - betahistine

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea / vomiting), hearing loss (hardness of hearing), tinnitus.

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

accord healthcare limited - betahistine dihydrochloride - tablets - 16 milligram - betahistine

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - betahistine dihydrochloride 8mg;   - tablet - 8 mg - active: betahistine dihydrochloride 8mg   excipient: citric acid monohydrate colloidal silicon dioxide mannitol microcrystalline cellulose purified talc

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; mannitol; citric acid monohydrate; purified talc - meniere's syndrome as defined by the following core symptoms: - vertigo (with nausea/vomiting): - hearing loss (hardness of hearing): - tinnitus.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus